Evaluates clinical and brain outcomes in APOE4/4 homozygotes with early Alzheimer's, suggesting potential benefits.
To evaluate valiltramiprosate/ALZ-801 effects on clinical and brain volume outcomes in the prespecified MCI group.
No takes yet. Share an insight, caveat, or question.
Abushakra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: